New World Health

Three Managing Partners run the firm: Adam Henick, the former President of Mount Sinai Ambulatory Ventures who brings clinical-operating networks; Isaac Oved, Founder and CEO of the Oved Group family office; and Dr. Joseph Hai Oved, who oversees the Oved Group's broader investment portfolio. The partnership structure suggests investment decisions are made collectively, combining hospital-system access with multi-generational family capital.

Managing Partner Adam Henick previously served as President of Mount Sinai Ambulatory Ventures, and the firm lists a strategic relationship with Mount Sinai through Henick and Dr. Edward Lung. New World Health is not a captive venture arm of the hospital system but appears to leverage clinical relationships for deal sourcing and diligence. The exact nature of any formal investment partnership or revenue-sharing arrangement has not been disclosed.

No. While the firm's name and founding team emphasize healthcare, New World Health also holds a concentrated portfolio of New York commercial and mixed-use real estate, including properties on 34th Street, in Chinatown, and the Italian American Museum building on Mulberry Street. It also holds O5 Apparel, a clothing manufacturer. The firm functions as a hybrid operator rather than a pure healthcare specialist.

Isaac Oved, Founder and CEO of the Oved Group family office, serves as Managing Partner of New World Health alongside Dr. Joseph Hai Oved, who is President of the Oved Group's investment portfolio. The Oved Group appears to provide balance-sheet capital and the real estate operating infrastructure for New World Health's property holdings, while Adam Henick contributes the healthcare sourcing expertise.

New World Health is structured as an investment company, not a pure family office, though its capital base is opaque. The presence of the Oved Group — a family office — as a managing partner suggests significant internal capital. No external fund closes, limited partners, or institutional fund structures have been publicly disclosed. The firm's regulatory posture and capital-raising activity remain unverified.

Yes, the firm maintains the New World Health Foundation. Grant-making priorities, asset size, and governance details have not been publicly disclosed. The foundation's existence signals an intention to direct capital toward health-related giving, but its separation from the investment entity — a standard governance concern for allocators evaluating potential conflicts — is not documented.

The firm describes its healthcare strategy as targeting early-stage companies. Specific check sizes, follow-on policies, and whether it leads or participates in rounds have not been disclosed publicly. Given the balance-sheet nature of its capital and the absence of disclosed fund vehicles, check sizes likely vary by opportunity rather than conforming to a rigid allocation model.